secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001618835-23-000011
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences raises ~$739k net via sale of convertible notes and warrants
-------------------------------------------------------------------------------

- Aggregate principal $1.38M; net proceeds ~$739k after expenses.
- Notes bear 8% interest, mature in 3 years, convertible at $0.02/share.
- Warrants exercisable at $0.02/share, expire in 5 years.
- Beneficial ownership limitation of 4.99% applies to conversion/exercise.
- Registration rights agreement filed for resale of underlying shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000011/0001618835-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000011/evfm-20230217.htm
  HTML page:      https://secwatch.observer/filing/0001618835-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer